Voxeljet (NASDAQ:VJET)
Historical Stock Chart
From Jul 2019 to Jul 2024
Webcast Alert for VisiJet, Inc.: Trilogy Capital's Emerging Growth Microcap
Forum Announces the Addition of Two Keynote Speakers To Today's Webcast at 12
p.m. ET
Richard Giest, Ph.D, and Paul Cohen to Speak
IRVINE, Calif., Nov. 21 /PRNewswire/ -- VisiJet, Inc. (BULLETIN BOARD:
VJET.OB) will webcast the following presentation:
What: VisiJet (OTC:VJET.OB) (BULLETIN BOARD: VJET.OB) will give a
presentation at
Informed Investors Emerging Growth/Microcap Stocks Forum
When: November 21, 2003 @ 12:00 PM Eastern Time
Where: http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=339
How: Live over the Internet -- Simply log on to the web at the address
above.
Contact: AJ Cervantes, Trilogy Capital, ,
800-330-1860
If you are unable to participate during the live webcast, the call will be
available for replay at
http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=339.
The keynote speakers today include Dr. Richard Geist, a well-known commentator,
financial analyst and author of the recent national publication, Investment
Therapy, available in major bookstores, as well as The Psychology of Investing,
which was published in 2001. Dr. Geist appears regularly as an analyst for such
programs as CNBC and CNN. In addition, Mr. Paul Cohen, the editor and publisher
of the Cohen Independent Research Report will also speak on Microcap investing
and the Microcap rationale.
VisiJet, Inc., a medical device company based in Irvine, California, is focused
on the development and marketing of innovative ophthalmic applications that will
result in faster, safer and more efficacious procedures in two of the largest
surgical markets in the world: refractive and cataract surgeries. VisiJet's lead
products, the HydroKeratome(R) and Pulsatome(R), utilize the Company's
proprietary and patented waterjet technology. These devices uses a high-pressure
micro beam of water the diameter of a human hair to cut ocular tissue. The
FDA-approved HydroKeratome(R), uses the waterjet technology to cut the cornea as
required in LASIK surgery. The Pulsatome(R), currently under development, is a
device that uses waterjet technology to remove cataracts -- the most performed
surgical procedure in the world.
For more information visit http://www.visijet.com/.
About Trilogy Capital
Trilogy's Emerging Growth Microcap Forums, hosted by InformedInvestor.com,
provide the perfect online forum for publicizing the compelling stories of
potentially high-growth Microcap companies. Trilogy is committed to identifying
overlooked and undervalued emerging growth companies that may be poised to
revolutionize their fields, create great products and deliver exceptional
performance for their investors.
Trilogy Capital Partners, Inc. is a proactive financial services company engaged
in corporate communications, investor relations and strategic planning. Based on
the simple concept that many well-run public companies are not realizing their
full value in the marketplace, Trilogy has aggregated highly experienced
executives into a formidable financial and marketing team. Our team utilizes
proactive, technology-driven strategies and tools to drive public company
visibility. For more information, please visit http://www.trilogy-capital.com/
or contact Racquel Rivera at .
FORUM CONTACT: Janet Scharr, Informed Investors, 804-327-3424,
DATASOURCE: VisiJet, Inc.
CONTACT: AJ Cervantes of Trilogy Capital, or
+1-800-330-1860 or Janet Scharr of Informed Investors, +1-804-327-3424,
Web site: http://www.informedinvestors.com/
http://www.trilogy-capital.com/
http://www.visijet.com/